fbpx

Researchers develop a new form of gene therapy that can stop cell division in a particularly aggressive type of cancer.

A new study presents a promising treatment method for so-called fusion-driven cancers, which are currently often difficult to cure. These fusion-driven cancers are caused by an error in cell division that creates a fusion of different genes. This fusion causes the cancer and drives the uncontrolled cell growth.

Read more

In-stent thrombosis after antiplatelet therapy conversion while awaiting coronary bypass

In a new publication from Cardiovascular Innovations and Applications Nathan Burke, Tawanna Charlton, Hussam Hawamdeh, and Ki Park from the University of Florida College of Medicine, Gainesville, Florida, USA consider a case study of in-stent thrombosis after antiplatelet therapy conversion while awaiting coronary bypass.

Read more
Enable notifications of new posts OK No thanks